Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05238779 · ClinicalTrials.gov registry record
An Integrative Model for Palliative Care in End-Stage Liver Disease
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 28
- Enrollment target
NCT05238779 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 28 participants.
The verdict
NCT05238779 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The purpose of this research study is to understand the impact of palliative care in ESLD on quality of life, emergency room or hospital visits, and on care provider burden, and to work to develop the best way to provide palliative care in ESLD.
Interventions
- OTHER Standard of care including palliative care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-01-06 |
| Est. Completion | 2022-12-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05238779
The ClinicalTrials.gov registry entry for NCT05238779 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Standard of care including palliative care is the first listed.
NCT05238779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05238779 about?
NCT05238779 is a clinical study titled "An Integrative Model for Palliative Care in End-Stage Liver Disease". The purpose of this research study is to understand the impact of palliative care in ESLD on quality of life, emergency room or hospital visits, and on care provider burden, and to work to develop the best way to provide palliative care in ESLD.
What is the current status of trial NCT05238779?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2022-01-06. Estimated completion is 2022-12-12.
What interventions are being tested in trial NCT05238779?
The interventions under investigation include: Standard of care including palliative care (OTHER).
Who is sponsoring clinical trial NCT05238779?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.